ATRC - AtriCure Inc Stock Price, Fair Value and News

22.10USD-1.43 (-6.08%)Market Closed

Market Summary

USD22.10-1.43

Market Closed

-6.08%

ATRC Stock Price

View Fullscreen

ATRC RSI Chart

ATRC Valuation

Market Cap

1.1B

Price/Earnings (Trailing)

-28.72

Price/Sales (Trailing)

2.58

EV/EBITDA

-54.05

Price/Free Cashflow

-43.25

ATRC Price/Sales (Trailing)

ATRC Profitability

Operating Margin

75.26%

EBT Margin

-8.81%

Return on Equity

-8.16%

Return on Assets

-6.29%

Free Cashflow Yield

-2.31%

ATRC Fundamentals

ATRC Revenue

Revenue (TTM)

414.6M

Rev. Growth (Yr)

16.43%

Rev. Growth (Qtr)

2.17%

ATRC Earnings

Earnings (TTM)

-37.2M

Earnings Growth (Yr)

-104.89%

Earnings Growth (Qtr)

-35.55%

Breaking Down ATRC Revenue

Last 7 days

-8.6%

Last 30 days

-3.9%

Last 90 days

-4.6%

Trailing 12 Months

-59.6%

How does ATRC drawdown profile look like?

ATRC Financial Health

Current Ratio

Debt/Equity

0.14

Debt/Cashflow

-0.2

ATRC Investor Care

Shares Dilution (1Y)

2.41%

Diluted EPS (TTM)

-0.8

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	414.6M	0	0	0
2023	349.3M	365.7M	380.7M	399.2M
2022	289.6M	302.8M	315.6M	330.4M
2021	212.6M	243.1M	258.8M	274.3M
2020	230.1M	212.0M	210.1M	206.5M
2019	208.6M	215.7M	222.4M	230.8M
2018	180.4M	187.0M	194.8M	201.6M
2017	160.4M	166.0M	169.8M	174.7M
2016	135.8M	142.9M	149.8M	155.1M
2015	112.5M	118.6M	123.3M	129.8M
2014	87.3M	93.4M	99.9M	107.5M
2013	72.2M	74.4M	78.4M	81.9M
2012	66.2M	67.7M	68.6M	70.2M
2011	60.7M	63.3M	64.0M	64.4M
2010	0	56.0M	57.5M	59.0M
2009	0	0	0	54.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

CEO	Mr. Michael H. Carrel
WEBSITE	atricure.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1050

AtriCure Inc Frequently Asked Questions

What is the ticker symbol for AtriCure Inc? What does ATRC stand for in stocks?

ATRC is the stock ticker symbol of AtriCure Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AtriCure Inc (ATRC)?

As of Fri Jul 26 2024, market cap of AtriCure Inc is 1.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATRC stock?

You can check ATRC's fair value in chart for subscribers.

Is AtriCure Inc a good stock to buy?

The fair value guage provides a quick view whether ATRC is over valued or under valued. Whether AtriCure Inc is cheap or expensive depends on the assumptions which impact AtriCure Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATRC.

What is AtriCure Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, ATRC's PE ratio (Price to Earnings) is -28.72 and Price to Sales (PS) ratio is 2.58. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ATRC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on AtriCure Inc's stock?

In the past 10 years, AtriCure Inc has provided 0.025 (multiply by 100 for percentage) rate of return.